Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brimonidine for neuroprotection in optic neuritis
IRCT20221127056631N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of brimonidine in optic neuritis (ON), sponsored by Zahedan University of Medical Sciences. Started Dec 2022; status: completed.
02
Drugs
brimonidine
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on IRCT20221127056631N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221127056631N1.